CG Oncology, Inc.
CGONNasdaqCIK 1991792HealthcareFiscal year ends Dec 31
Reports and events: 50 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0612:45 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-336918 |
| 2026-08-0612:30 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-336886 |
| 2026-06-0820:02 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-261670 |
| 2026-05-2612:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-237908 |
| 2026-05-0820:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-214669 |
| 2026-05-0812:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-213440 |
| 2026-04-2420:30 ET | DEF 14A | Proxy statementPeriod 2026-04-23 | 0001193125-26-177395 |
| 2026-04-1312:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-152044 |
| 2026-02-2714:00 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-079498 |
| 2026-02-2713:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-079452 |
| 2026-01-1321:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-011855 |
| 2026-01-0913:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-008329 |
| 2025-11-2612:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-298160 |
| 2025-11-1421:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-283108 |
| 2025-11-1421:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-283000 |
| 2025-11-1413:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-281672 |
| 2025-10-2821:12 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001013594-25-001271 |
| 2025-09-1800:37 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-25-207734 |
| 2025-09-1800:22 ET | SCHEDULE 13D | Ownership report, active investor | 0001013594-25-001163 |
| 2025-09-0911:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001991792-25-000007 |
| 2025-09-0511:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001991792-25-000004 |
| 2025-08-0820:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105855 |
| 2025-08-0812:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105487 |
| 2025-07-1120:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-095296 |
| 2025-06-0620:15 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-083088 |
| 2025-05-1312:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-069831 |
| 2025-05-1312:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069825 |
| 2025-04-2811:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-058956 |
| 2025-04-2512:05 ET | DEF 14A | Proxy statementPeriod 2025-06-05 | 0000950170-25-058342 |
| 2025-03-2812:59 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-046351 |
| 2025-03-2811:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-046335 |
| 2025-03-2412:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-043497 |
| 2025-01-1021:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-004168 |
| 2024-12-1121:09 ET | S-1/A | Registration statement, amended | 0001193125-24-275552 |
| 2024-12-1111:06 ET | S-1 | Registration statement | 0001193125-24-274822 |
| 2024-12-0512:52 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-271116 |
| 2024-11-1213:17 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-124642 |
| 2024-11-1213:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124636 |
| 2024-08-0810:19 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093238 |
| 2024-08-0810:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093237 |
| 2024-05-2412:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-064309 |
| 2024-05-0912:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-134805 |
| 2024-05-0910:07 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-056196 |
| 2024-05-0320:31 ET | 8-K | 8.01 Other events | 0001193125-24-130800 |
| 2024-03-2610:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-036143 |
| 2024-02-1621:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-038506 |
| 2024-01-3012:10 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-018715 |
| 2024-01-2311:06 ET | S-1/A | Registration statement, amended | 0001193125-24-012523 |
| 2024-01-1811:04 ET | S-1/A | Registration statement, amended | 0001193125-24-009621 |
| 2024-01-0222:16 ET | S-1 | Registration statement | 0001193125-24-000766 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.